Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peer Tfelt-Hansen

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Headache|January 31, 2009
Early responses in randomized clinical trials of triptans in acute migraine treatment. Are they clinically relevant? A commentPeer Tfelt-Hansen
Headache|March 12, 2015
The qualitative problem of major quotation errors, as illustrated by 10 different examples in the headache literaturePeer Tfelt-Hansen
CNS Drugs|February 18, 2011
Pain freedom at 2 hours in migraine after telcagepant 300 mgPeer Tfelt-Hansen
Headache|November 13, 2010
Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migrainePeer Tfelt-Hansen
CNS Drugs|January 25, 2011
Low efficacy of transdermal sumatriptan in migrainePeer Tfelt-Hansen
The Journal of Headache and Pain|May 15, 2007
Acute pharmacotherapy of migraine, tension-type headache, and cluster headachePeer Tfelt-Hansen
Ugeskrift for Laeger|May 12, 2009
[Triptans versus other migraine medicine--secondary publication]Peer Tfelt-Hansen
Lancet (London, England)|March 24, 2009
Migraine and telcagepant [corrected]Peer Tfelt-Hansen
Headache|June 21, 2007
Gastric emptying in migrainePeer Tfelt-Hansen
The Journal of Headache and Pain|March 2, 2011
Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trialPeer Tfelt-Hansen
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Headache|January 31, 2009
Early responses in randomized clinical trials of triptans in acute migraine treatment. Are they clinically relevant? A commentPeer Tfelt-Hansen
Headache|March 12, 2015
The qualitative problem of major quotation errors, as illustrated by 10 different examples in the headache literaturePeer Tfelt-Hansen
CNS Drugs|February 18, 2011
Pain freedom at 2 hours in migraine after telcagepant 300 mgPeer Tfelt-Hansen
Headache|November 13, 2010
Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migrainePeer Tfelt-Hansen
CNS Drugs|January 25, 2011
Low efficacy of transdermal sumatriptan in migrainePeer Tfelt-Hansen
The Journal of Headache and Pain|May 15, 2007
Acute pharmacotherapy of migraine, tension-type headache, and cluster headachePeer Tfelt-Hansen
Ugeskrift for Laeger|May 12, 2009
[Triptans versus other migraine medicine--secondary publication]Peer Tfelt-Hansen
Lancet (London, England)|March 24, 2009
Migraine and telcagepant [corrected]Peer Tfelt-Hansen
Headache|June 21, 2007
Gastric emptying in migrainePeer Tfelt-Hansen
The Journal of Headache and Pain|March 2, 2011
Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trialPeer Tfelt-Hansen
Pageof 11